Dental Health

Thank you for the summary of that documentary @meadow_wind - I'm definitely going to check that out.
My wife has just been diagnosed with Periodontal Disease, and of course, has been scheduled for a root canal procedure.
This article from Unbekoming came at the right time and was a real eye-opener - I've heard it said many a time (or read in different places) that oral health is a window to overall health, but I didn't really grok what that meant. Now I have a better idea and I'm going to keep digging. It seems that Unbekoming has published a book on dental health, 'Drilling for Profit: The Dietary Truth Behind Dental Disease' (for paid subscribers). I'm going to start there.
In the meantime, I've explained the above linked article to my wife and have hopefully convinced her that a good first step is get those troublesome carbohydrates out of her diet. That, and taking the 'Ultimate D3 supplement from DCM.
The cleaning schedule the dentist recommended, I now understand, is an entirely superficial response to what is fundamentally a systemic health issue. It will also keep her returning as a paying customer.
I feel a bit like I'm treading a fine line here. I've been eating a ketogenic / carnivore diet for a number of years, and whilst I've spoken about it a great deal with my wife, she's never felt as though she wanted to give it a go, and I haven't laboured the issue because it's not for me to determine what's good for her. I can only hope that this 'lesson' won't be too painful. I really don't want to see her suffering.
Now, a significant question, given the summary from the documentary above: what about the root canal that is scheduled a week on Saturday?

I'd say have a conversation with her, expressing yourself from a place of care and concern based on what you've learned - but then you just gotta leave it up to her.
 
Thank you @iamthatis.
So, I downloaded and read Unbekoming's book 'Drilling for Profit: The Dietary Truth Behind Dental Disease'. Then my wife and I read a few chapters together and discussed it.
As it turns out, her tooth started to get a lot more painful over the weekend. She called the dentist and had a consultation - the dentist agreed to remove the tooth rather than doing the root canal. Removing the tooth isn't exactly ideal (especially if the dentist doesn't remove all of the dental ligament), but on balance I think its the lesser of two evils.
This whole process was quite the learning experience for us both in the end - I can't recommend Unbekoming's book enough. I had no idea what a root canal was or what it involves:

The procedure is presented to patients as tooth preservation — a way to save a damaged tooth rather than extract it. What it actually involves is this: the nerve and blood supply are removed from the interior of the tooth, the hollow chamber is filled with a rubber compound called gutta percha, and the dead structure is cemented back into the jaw. The tooth has no blood circulation, no nerve sensation, no immune response, no capacity for self-repair. It is, by every biological definition, a dead organ left inside a living body.
(Drilling for Profit: The Dietary Truth Behind Dental Disease, page 65)
The normal oral streptococci bacteria that are left inside the tooth (on the dentinal tubules), in their new anaerobic environment mutate and become more virulent. The still porous tooth leaks pathogenic material (a focal infection) and can cause a disturbing list of issues:

coronary heart disease, stroke, Alzheimer's disease, diabetes, kidney disease, cancer of the lung, kidney, pancreas, and blood, rheumatoid arthritis, high blood pressure, obesity, pneumonia, epilepsy, and a host of autoimmune and inflammatory conditions.
(ibid)
In short, I'm relieved that my wife decided to take the root canal option off the table. :-O
 
Scientists have regrown adult teeth directly in the mouth.

South Korea Has Developed a Patch That Can Regrow Teeth, Ending the Need for Dentures Forever
November 28, 2025 by Miranda Lindale

South Korean researchers have developed a bioactive patch containing growth factors that stimulates natural tooth regeneration in adult humans, potentially eliminating the need for dental implants and dentures. The technology, developed at Seoul National University’s School of Dentistry, uses recombinant proteins to reactivate dormant tooth stem cells in the jaw, triggering the biological processes that normally only occur during childhood tooth development. Early clinical trials report successful regeneration of tooth buds in human patients after 2-3 months of treatment, though complete functional teeth require 9-12 months to fully mature. This breakthrough addresses a fundamental limitation in dental medicine—that unlike many tissues, human teeth cannot naturally regenerate after damage or loss in adulthood. Understanding how this technology works, its current development status, and realistic expectations for future availability provides essential context for evaluating this remarkable scientific advancement.

Table of Contents
The Biology of Tooth Development and Loss
The Korean Tooth Regeneration Technology
Clinical Trial Results and Development Timeline
Comparison to Existing Dental Restoration Options
Scientific Challenges and Limitations
Future Directions and Broader Implications
Maintaining Dental Health While Awaiting Future Technology
Sources

The Biology of Tooth Development and Loss
Human tooth development begins in utero through complex interactions between epithelial and mesenchymal tissues. Specific molecular signals activate dental stem cells, initiating a cascade of events that forms tooth buds, which gradually mineralize into functional teeth. Children possess two sets: 20 primary teeth that emerge by age 3, and 32 permanent teeth that replace them by early adulthood.

Once permanent teeth fully develop, humans lose the natural capacity for tooth regeneration. Most vertebrates, including sharks and alligators, continuously replace teeth throughout their lives through sustained stem cell activity. Mammals, however, evolved a different strategy—producing two sets of highly specialized teeth rather than continuous replacement. This evolutionary trade-off provided stronger, more precise teeth for complex food processing but eliminated regenerative capacity.

Adult humans retain dormant dental stem cells in the jaw and tooth structures, but these cells lack the molecular signals needed to reactivate tooth development. Research suggests these quiescent cells maintain developmental potential but require specific growth factor combinations to trigger differentiation into new tooth structures. The challenge facing regenerative dentistry has been identifying which signals to provide and how to deliver them effectively to dormant stem cells.

Approximately 178 million Americans are missing at least one tooth, while 40 million have lost all their teeth, according to the American College of Prosthodontists. Traditional solutions include dentures, bridges, and titanium implants surgically anchored into the jawbone. While functional, these prosthetics never fully replicate natural teeth in terms of sensation, bone preservation, or integration with surrounding tissues.

The Korean Tooth Regeneration Technology
The Seoul National University team developed a dissolvable patch approximately 5 millimeters square that adheres directly to the gum tissue at the site of missing teeth. The patch contains recombinant human bone morphogenetic protein 2 (BMP-2) and Wnt pathway activators—two critical molecular signals involved in embryonic tooth development.

BMP-2 belongs to a protein family that regulates bone and cartilage formation throughout the body. Studies indicate BMP-2 specifically triggers dental stem cells to differentiate into odontoblasts, the cells that produce dentin, the hard tissue forming the bulk of tooth structure. The protein concentration in the patch reaches approximately 100 micrograms per square centimeter, delivered gradually as the biocompatible polymer matrix dissolves over 2-3 weeks.

Wnt signaling pathways control numerous developmental processes, including tooth formation. Preliminary findings suggest Wnt activators in the regeneration patch stimulate epithelial stem cells to form enamel-producing ameloblasts while simultaneously promoting supporting tissue development. The combination of BMP-2 and Wnt activation recreates the molecular environment present during natural tooth development.

The patch’s polymer matrix consists of polylactic-co-glycolic acid (PLGA), a biodegradable material widely used in medical applications including dissolvable sutures. As the PLGA gradually breaks down, it releases growth factors in a controlled temporal pattern that mimics natural developmental sequences. This sustained release ensures stem cells receive appropriate signals over the weeks required for initial tooth bud formation.

Clinical Trial Results and Development Timeline
Phase I clinical trials conducted between 2022 and 2024 enrolled 45 adult participants aged 25-65 who had lost single molars within the previous five years. Researchers applied the regeneration patch monthly for three months, then monitored participants using dental imaging and biopsy sampling. Results published in the Journal of Dental Research reported tooth bud formation in 38 participants (84%) within 90 days of initial treatment.

Micro-CT imaging revealed mineralized tissue structures consistent with early-stage tooth development. By month six, 31 participants (69%) showed continued tooth growth with recognizable crown structures emerging above the gum line. At 12 months, 24 participants (53%) had regenerated functional tooth structures capable of bearing chewing forces, though these teeth remained smaller and less mineralized than fully mature natural teeth.

The research team emphasized that current results represent proof of concept rather than ready-for-market therapy. The regenerated teeth exhibited several limitations including incomplete enamel formation, reduced mineral density compared to natural teeth, and inconsistent size and shape. Additionally, 16% of participants experienced no response to treatment, and several reported temporary gum inflammation at the patch application site.

Phase II trials expanded to 200 participants in 2024, testing optimized growth factor formulations and extended treatment protocols. Preliminary findings suggest that applying patches for six months rather than three increases the success rate to approximately 75%, with improved tooth quality. However, complete results won’t be available until 2026 when participants complete the full 18-month observation period.

The research team projects that Phase III trials involving thousands of participants could begin in 2027 if Phase II results prove successful. Regulatory approval processes in South Korea typically require 3-5 years after Phase III completion, suggesting potential clinical availability around 2032-2034 under optimistic scenarios. International approval in other countries would follow different timelines depending on respective regulatory frameworks.

Comparison to Existing Dental Restoration Options
Understanding tooth regeneration technology requires comparing it to established alternatives. Dental implants, the current gold standard for single tooth replacement, involve surgically placing a titanium post into the jawbone that serves as an artificial root. After 3-6 months of bone integration, dentists attach a ceramic crown to the post, creating a functional tooth replacement.

Implants cost $3,000-6,000 per tooth in the United States, involving surgical procedures with associated infection risks and healing time. Studies indicate implant success rates around 95% over 10 years, though complications including implant failure, bone loss, and peri-implantitis occur in 5-10% of cases. Implants provide excellent function and aesthetics but lack the biological integration and sensory feedback of natural teeth.

Dentures represent a non-surgical alternative, particularly for multiple missing teeth. Full dentures cost $1,000-3,000 and require no surgery, but they rest on the gums rather than anchoring in bone. This leads to gradual jawbone resorption since bone requires mechanical stress from tooth roots to maintain density. Research suggests denture wearers lose 0.5-1.0 millimeters of jawbone height per year, eventually compromising facial structure and denture fit.

Tooth regeneration offers potential advantages over both approaches by restoring natural biological structures with intact nerve connections, blood supply, and periodontal ligaments that anchor teeth in sockets. These features provide sensation, immune function, and mechanical properties that prosthetics cannot replicate. However, the regeneration process requires many months, and success rates currently fall below implant success rates.

Scientific Challenges and Limitations
Despite promising early results, several substantial obstacles must be overcome before tooth regeneration becomes clinically viable. The primary challenge involves controlling tooth morphology—ensuring regenerated teeth develop appropriate size, shape, and orientation for proper function. Natural tooth development involves precise spatial and temporal regulation of hundreds of genes, and current technology activates only a fraction of these pathways.

Early trial participants frequently experienced regenerated teeth with irregular crown shapes, misaligned roots, or inappropriate positioning relative to adjacent teeth. Studies indicate these problems stem from incomplete recapitulation of the natural developmental program. Researchers are investigating whether additional growth factors, including fibroblast growth factors and hedgehog signaling molecules, might improve developmental precision.

Age-related changes in stem cell populations present another significant challenge. Research suggests dental stem cell populations decline with age, and remaining cells show reduced proliferative capacity and differentiation potential. Trials found lower success rates in participants over 50, possibly reflecting age-related stem cell dysfunction. Strategies to rejuvenate aging stem cells or supplement with donor cells might address this limitation.

The technology currently works only for recently lost teeth where sufficient stem cell populations remain in the jaw. Patients who lost teeth decades ago often have insufficient stem cells for regeneration to succeed. Additionally, jawbone resorption following long-term tooth loss creates geometric challenges for new tooth positioning. These factors suggest tooth regeneration may serve as an immediate alternative to implants rather than a solution for long-term edentulism.

Individual variation in treatment response remains poorly understood. Some participants regenerate teeth quickly with excellent morphology, while others show minimal response despite identical protocols. Preliminary findings suggest genetic factors, immune system variations, and local tissue conditions influence outcomes, but researchers haven’t identified specific predictive markers to determine which patients will respond favorably.

Future Directions and Broader Implications
Beyond the current patch technology, researchers are exploring complementary approaches to enhance tooth regeneration. Gene therapy techniques could potentially introduce growth factor genes directly into stem cells, providing sustained local production rather than external delivery. Early animal studies show promising results, though human applications remain years away pending safety evaluations.

Three-dimensional bioprinting represents another frontier in dental regeneration. Scientists are developing methods to print cell-laden scaffolds with precise tooth geometry, potentially overcoming the morphological control problems affecting current regeneration approaches. These bioprinted tooth buds would contain appropriate cell types arranged in natural configurations, theoretically improving developmental outcomes.

The broader implications extend beyond dental applications. Success in stimulating adult tooth regeneration would demonstrate that human tissues previously considered non-regenerative can regrow when provided with appropriate molecular signals. This principle might extend to other regeneration challenges including hair follicles, salivary glands, or even more complex structures like damaged organs.

The economic impact could transform the dental industry, which generates over $140 billion annually in the United States alone. If tooth regeneration becomes widely available and cost-effective, it would disrupt markets for dental implants, dentures, bridges, and related surgical procedures. However, this transition would occur gradually over decades as technology matures and gains regulatory approval.

Maintaining Dental Health While Awaiting Future Technology
Given the extended timeline before regeneration therapy becomes available, maintaining natural tooth health remains paramount. The American Dental Association recommends brushing twice daily with fluoride toothpaste, daily flossing, and professional cleanings every six months. These practices prevent the tooth decay and gum disease that cause 90% of tooth loss.

Dietary choices significantly impact dental health. Limiting sugar consumption reduces acid-producing bacteria that erode enamel, while calcium-rich foods provide minerals for maintaining tooth structure. Studies indicate that adults consuming less than 25 grams of added sugar daily show substantially lower rates of dental decay compared to those exceeding 50 grams daily.

For individuals who have already lost teeth, existing restoration options provide proven functionality while regeneration technology continues developing. Consulting with dental professionals about implants, bridges, or dentures addresses immediate functional and aesthetic needs. These solutions can potentially be replaced with regenerated teeth once the technology becomes clinically available in future decades.

The South Korean tooth regeneration research represents a genuine scientific breakthrough that successfully stimulates adult tooth regrowth in humans for the first time, though substantial development work remains before clinical availability. Current results demonstrate biological feasibility while highlighting challenges including incomplete development, morphological irregularities, and variable patient response that require resolution. The realistic timeline projects potential clinical availability around 2032-2034 in South Korea, with international availability following over subsequent years. For individuals interested in this emerging field, monitoring peer-reviewed publications from dental research institutions and following announcements from regulatory agencies like the Korean Ministry of Food and Drug Safety will provide authoritative updates as this technology progresses through the remaining development and approval phases required before it can transform dental medicine.

Sources
Kim, J. Y., et al. “Bioactive Growth Factor Delivery for Adult Tooth Regeneration.” Journal of Dental Research, Vol. 102, 2023.

Seoul National University School of Dentistry. “Clinical Trial Results: Tooth Regeneration Using BMP-2/Wnt Combination Therapy.” Research Publications, 2024.

American College of Prosthodontists. “Facts and Figures: Missing Teeth.” Clinical Statistics Report, 2023.

Thesleff, I., et al. “Molecular Mechanisms of Tooth Development and Regeneration.” Nature Reviews Molecular Cell Biology, Vol. 15, 2014.

Sharpe, P. T. “Dental Mesenchymal Stem Cells.” Development, Vol. 143, 2016.

Korean Ministry of Food and Drug Safety. “Regenerative Medicine Clinical Trial Guidelines.” Regulatory Framework Documents, 2024.

Humans Have a Third Set of Teeth. New Medicine May Help Them Grow.
They could be ready by 2030.
By Tim Newcomb
Published: Feb 15, 2026 7:44 AM EST

Here’s what you’ll learn when you read this story:
A study out of Japan showed how targeting genes can regrow teeth in animals. Now, the team has turned to a human clinical trial.
By targeting the USAG-1 gene, researchers believe that they can help people without a full set of teeth regrow teeth.
The team says that humans have a third set of teeth available as buds, ready to grow as needed.

A sliver of what makes sharks so intriguing comes with their ability to regrow teeth. And while a group of Japanese researchers aren’t claiming that we should be trying to be the most shark-like possible, they’d like for us to maybe, someday, share that same ability.

Following up on a 2021 study (published in Scientific Reports) that showed how medicine targeting the protein synthesized by the USAG-1 gene could impact the number of teeth grown in animals, the team has turned its attention to humans. In 2024, they started a clinical trial of the medicine, which they hope to have ready for general use in 2030.

“The idea of growing new teeth is every dentist’s dream. I’ve been working on this since I was a graduate student. I was confident I’d be able to make it happen,” Katsu Takahashi, lead researcher and head of the dentistry and oral surgery department at the Medical Research Institute Kitano Hospital in Osaka, told Mainichi. “We’re hoping to see a time when tooth regrowth medicine is a third choice alongside dentures and implants.”

Takahashi has spent years researching the regrowth potential of teeth, and has focused on the role of genes in this process. “The number of teeth varied through the mutation of just one gene,” he said. “If we make that the target of our research, there should be a way to change the number of teeth (people have).”

Researchers found that the USAG-1 protein could limit the growth of teeth in mice, so ensuring that the protein didn’t form could potentially invite teeth to grow. The team developed a medication to block the protein, and successfully allowed mice to grow new teeth.

A 2023 paper published in Regenerative Therapy decries the lack of treatments available for tooth regrowth, but highlights how the anti-USAG-1 antibody treatment in mice could offer “a breakthrough in treating tooth anomalies in humans.”

With about 1 percent of humans suffering from anodontia, a genetic condition that doesn’t allow a full set of teeth to grow, there is hope for tooth regrowth in humans beyond just mice-centric trials.

And that hope, Takahashi claims, should be further encouraged by the fact that we already come pre-loaded with the starting point. He said that his previous research shows that humans have the start of a third set of teeth already embedded in our mouths. This is most visibly exhibited by the 1 percent of humans with hyperdontia, the growing of more than a full set of teeth. And Takahashi believes that activating that third set of buds with the right gene manipulation could promote tooth regrowth.

If all goes well in the clinical trial, the world may have more teeth as soon as 2030.
 
Back
Top Bottom